For Mitsubishi Pharma Corporation, ensuring business activity that takes account of global environmental conservation is an extension of the same approach as providing safe and effective pharmaceuticals. In order to reduce environmental burden at all stages of the pharmaceutical lifecycle, from research and development through manufacture and distribution to consumption, it is important to put firmly in place systems for action on environmental conservation and to ensure the stable operation of these systems. Above all, a strong commitment to protecting the global environment is needed. At Mitsubishi Pharma, in addition to moving forward with the acquisition of ISO14001 certification at business bases, we will continue with efforts to manage chemical substances, prevent global warming, reduce waste emissions, and protect the atmosphere and waterways as part of continuous action to reduce environmental burden and preserve the glory of the natural environment.
Safe management and use of chemical substances
Chemical substances are highly useful substances which are indispensable to pharmaceutical research and manufacture. At the same time, there are a large number of chemical substances where risk assessment to clarify their impact on the natural environment has not yet produced a sufficiently clear result. It is therefore important to be aware of the latent risk of all chemical substances utilized. At Mitsubishi Pharma, our handling of chemical substances is founded on measures to make sure that residents of surrounding areas or people in the workplace are not exposed to chemical substances and to reduce to a minimum the release of substances into the atmosphere and waterways.
At the same time as using chemical substances, we are committed to promoting safe control and use by enhancing sensitivity to risk and by rapidly gathering domestic and overseas risk data, information on assessment methods, and related information.
Measures to prevent global warming
Global warming is an environmental issue which requires an urgent global-scale solution. At Mitsubishi Pharma, we are promoting maximum efficiency in the use of fossil fuel, while all domestic and overseas bases of the Mitsubishi Pharma Group are taking active measures against global warming.
Mitsubishi Pharma has joined Nippon Keidanren’s Voluntary Action Plan on the Environment and has aligned itself with the target announced by the Japan Pharmaceutical Manufacturers Association: to reduce the CO2 emissions volume of pharmaceutical manufacturers for fiscal year 2010 to below the level of fiscal year 1990. In line with these commitments, we are rolling out measures to reduce CO2 emissions volume at Mitsubishi Pharma Group manufacturing plants and research laboratories, distribution center office buildings, and other business premises, with efforts centered mainly on energy conservation activity.